Panitumumab Biosimilar - Research Grade,ichor.bio,ICH4028
Detects human EGFR. This non-therapeutic antibody uses the same sequence as the therapeutic antibody Panitumumab.
Host
Humanized
Reactivity
Human
Platform ID
BAB700819061
ichor.bio
Contact
Tel:
Fax:
Email:
Product Specifications
Scientific Background
Synonyms
Specifications
NamePanitumumab Biosimilar - Research Grade
Cat. No.ICH4028
Accession NumberP00533
HostHumanized
IsotypeHuman IgG2 kappa
ReactivityHuman
Concentration1.0 - 5.0 mg/ml
TargetEGFR
Purity>95% by SDS-PAGE and HPLC
Endotoxin Level≤ 1.0 EU/mg as determined by the LAL method
ShippingBlue ice
FormulationICH3001-100ml
ICH3002-100ml
ICH3003-100ml
StorageStable for at least one week when stored sterile at 2-8°C. For long term storage aseptically aliquot in working volumes without diluting and store at -80°C. Avoid Repeated Freeze Thaw Cycles.
Regulatory StatusFor research use only
Scientific Background
Panitumumab biosimilar is a recombinant, human IgG2 kappa monoclonal antibody that binds specifically to the human epidermal growth factor receptor (EGFR). It has an approximate molecular weight of 147 kDa and is produced in genetically engineered mammali
Synonyms
Epidermal growth factor receptor, Proto-oncogene c-ErbB-1, Receptor tyrosine-protein kinase erbB-1, ERBB, ERBB1, HER1
Category Paths
- Products>Primary Antibodies>Biosimilar Antibodies
Request a product
Please provide the required information below so that we can quickly source your products.